- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨126.7b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨403.03
7D
-5.2%
1Y
153.5%
Hoechst Pakistan
Market Cap: PK₨36.0b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,731.71
7D
-2.5%
1Y
82.3%
Highnoon Laboratories
Market Cap: PK₨62.2b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,173.05
7D
-3.6%
1Y
57.8%
Abbott Laboratories (Pakistan)
Market Cap: PK₨110.6b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,149.99
7D
-2.9%
1Y
53.9%
AGP
Market Cap: PK₨53.2b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨193.54
7D
-8.8%
1Y
96.3%